NASDAQ$SKIN

SkinHealth Systems Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Headline financials

Total Revenue

$46.7M

No prior period
EPS (adj)

-$0.58

No prior period
Gross Margin

30.3%

No prior period
Adjusted EBITDA

-$1.1M

No prior period
Adjusted Gross Margin

51.0%

No prior period
Capital Expenditures

$1.32M

No prior period
Free Cash Flow

-$13M

No prior period
Net Income

-$10.4M

No prior period
Operating Income

-$7.92M

No prior period
Gross Profit

$4.28M

No prior period
Cash & Equivalents

$14.6M

No prior period
Stock-Based Comp

$250K

No prior period

Revenue & EPS history

Beauty Health · Revenue · Quarterly

$46.7M

Q2 2020
Beat estimate in 6 of 10 quarters(60%)
ActualEstimate

Revenue by segment

Beauty Health · $14.1M total across 2 segments · Q2 2020

  • Consumables
    $8.1M
  • Delivery Systems
    $6M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.9%

Avg return

30 days after

52%

12 / 23 earnings

Positive

+52.1%

Q1 2025

Best reaction

-61.4%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-29.9%-34.9%
Q4 2025+19.8%+11.3%-15.3%
Q3 2025+8.7%+3.1%+13.2%
Q1 2025+52.1%+19.4%+29.0%
Q4 2024-5.6%-9.9%-26.1%
Q3 2024+5.1%-13.1%-14.2%
Q2 2024-10.4%+0.8%+12.8%
Q1 2024-20.1%-18.4%-39.9%
Q4 2023+16.8%-0.8%+4.4%
Q3 2023-61.4%-37.2%-14.7%
Q2 2023-6.0%-12.9%-24.2%
Q1 2023-2.8%-0.2%-20.8%
Q4 2022+8.7%+13.5%+7.4%
Q3 2022-25.3%-12.3%-4.1%
Q2 2022-8.3%-8.8%-18.5%
Q1 2022-5.4%+6.6%+8.9%
Q4 2019+4.0%-4.1%-12.9%
Q4 2021+23.4%+43.1%+27.6%
Q3 2021-11.9%-8.0%-13.9%
Q2 2020+8.2%+7.4%+26.8%
Q2 2021+10.6%+23.9%+30.3%
Q1 2021+12.8%+15.9%+44.7%
Q4 2020+2.8%-0.9%-10.0%
Q3 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro